{"brief_title": "A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)", "brief_summary": "The purpose of this study is to test the safety, tolerability and effectiveness of an investigational drug and dietary supplement to reduce the risk of vitamin D insufficiency and deficiency during the treatment of osteoporosis in men and postmenopausal women.", "condition": ["Osteoporosis", "Vitamin D Deficiency"], "intervention_type": ["Drug"], "intervention_name": ["MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weeks"], "criteria": "Inclusion Criteria: - Men or postmenopausal women who are osteoporotic Exclusion Criteria: - Vitamin D deficiency - Other disease of bone or mineral metabolism - Digestive disease causing malabsorption - Other significant medical conditions that are not adequately treated", "gender": "All", "minimum_age": "40 Years", "maximum_age": "90 Years", "healthy_volunteers": "No", "mesh_term": ["Osteoporosis", "Vitamin D Deficiency", "Alendronate", "Cholecalciferol"], "id": "NCT00092066"}